Publicaciones en colaboración con investigadores/as de Necker-Enfants Malades Hospital (15)

2022

  1. Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 79, Núm. 20, pp. 1986-1997

  2. Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic Cardiomyopathy

    Circulation. Arrhythmia and electrophysiology, Vol. 15, Núm. 5, pp. e010075

2021

  1. Association Between Laryngopharyngeal Reflux and Media Otitis: A Systematic Review

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, Vol. 42, Núm. 7, pp. e801-e814

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Prediction of pre-eclampsia in twin pregnancy by maternal factors and biomarkers at 11–13 weeks' gestation: data from EVENTS trial

    Ultrasound in Obstetrics and Gynecology, Vol. 57, Núm. 2, pp. 257-265

2019

  1. An integrated molecular diagnostic report for heart transplant biopsies using an ensemble of diagnostic algorithms

    Journal of Heart and Lung Transplantation, Vol. 38, Núm. 6, pp. 636-646

2018

  1. Exploring the cardiac response to injury in heart transplant biopsies

    JCI insight, Vol. 3, Núm. 20

2015

  1. Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey

    Clinical Microbiology and Infection, Vol. 21, Núm. 6, pp. 604.e1-604.e9

  2. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

    PLoS Medicine, Vol. 12, Núm. 3

  3. Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A randomised, open-label, non-inferiority trial

    The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 785-792

  4. Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years

    Arthritis and Rheumatology, Vol. 67, Núm. 10, pp. 2759-2770

2014

  1. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

    AIDS, Vol. 28, Núm. 16, pp. 2461-2473

2010

  1. Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis

    Arthritis and Rheumatism, Vol. 62, Núm. 6, pp. 1792-1802

2005

  1. Use of neoral C2 monitoring: A European consensus

    Transplant International, Vol. 18, Núm. 7, pp. 768-778

2002

  1. Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia

    Blood, Vol. 100, Núm. 12, pp. 3877-3886